Skip to main content

Table 2 Risk factors for development of critical illness polyneuromyopathy

From: Is plasma calcium concentration implicated in the development of critical illness polyneuropathy and myopathy?

Variable

Patients with CIPNM (n= 40)

Patients without CIPNM (n= 150)

P value

Age

68.7 ± 15.7

66.4 ± 15.9

0.55

Female gender

24

39

0.002

APACHE II score

23.7 ± 6.5

20.1 ± 7

0.04

SOFA score

8.4 ± 4.1

7.8 ± 4.2

0.16

Aminoglucosides

20

52

0.18

Corticosteroids

28

102

0.84

NMBA

16

40

0.35

Septic shock

33

93

0.04

Hyperglycemia

10

43

0.66

Hyperkalemia

0

1

1

Hypokalemia

5

14

0.49

Hypernatremia

6

9

0.14

Hyponatremia

7

30

0.89

Hypercalcemia

4

3

0.01

Hypocalcemia

37

114

0.02

  1. APACHE, Acute Physiology and Chronic Health Evaluation; CIPNM, critical illness polyneuromyopathy; NMBA, neuromuscular blocking agents; SOFA, Sequential Organ Failure Assessment.